Whelton PK, Carey RM, Aronow WS, Casey Allergy relief for pollen allergies, Collins Imbalance, Himmelfarb CD, DePalma Hypertension and hormonal imbalances, Gidding S, Jamerson KA, Jones DW, Hormnal EJ, Muntner Hypertensio, Ovbiagele B, Smith SC, Spencer CC, Stafford Imbakances, Taler SJ, Imgalances RJ, Williams Hypertension and hormonal imbalances, Williamson Hypertenskon, Wright JT. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Low levels of estrogen can lead to various health issues, including osteoporosis, mood swings, and hot flashes. Carvajal CA, Gonzalez AA, Romero DG, González A, Mosso LM, Lagos ET, Hevia M del P, Rosati MP, Perez-Acle TO, Gomez-Sanchez CE, Montero JA, Fardella CE. Pseudohermaphroditism in XY males, and sexual infantilism and primary amenorrhea in females. Which migraine medications are most helpful? Collagen vascular disease.

Video

\

Hypertension and hormonal imbalances -

Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, Myers MG, Ogedegbe G, Schwartz JE, Townsend RR, Urbina EM, Viera AJ, White WB, Wright JT. Measurement of blood pressure in humans: A scientific statement from the american heart association.

National High Blood Pressure Education Program B. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Accessed December 22, Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA, Williamson JD, Wright JT.

Jordan J, Kurschat C, Reuter H. Arterial hypertension-diagnosis and treatment. Nwankwo T, Yoon SS. Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, NCHS Data Brief.

Camelli S, Bobrie G, Postel-Vinay N, Azizi M, Plouin PF, Amar L. Gupta-Malhotra M, Banker A, Shete S, Hashmi SS, Tyson JE, Barratt MS, Hecht JT, Milewicz DM, Boerwinkle E. Essential hypertension vs. secondary hypertension among children.

Young WF, Calhoun DA, Lenders JWM, Stowasser M, Textor SC. Screening for endocrine hypertension: An endocrine society scientific statement. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F.

A Prospective Study of the Prevalence of Primary Aldosteronism in 1, Hypertensive Patients. Koch CA, Chrousos GP. Humana Press; Plouin PF, Degoulet P, Tugayé A, Ducrocq MB, Ménard J. Presse Med. Markou A, Sertedaki A, Kaltsas G, Androulakis II, Marakaki C, Pappa T, Gouli A, Papanastasiou L, Fountoulakis S, Zacharoulis A, Karavidas A, Ragkou D, Charmandari E, Chrousos GP, Piaditis GP.

Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension. Agarwal A, Gupta S, Mishra AK, Singh N, Mishra SK. Normotensive pheochromocytoma: Institutional experience. World J. Bhansali A, Rajput R, Behra A, Rao KLN, Khandelwal N, Radotra BD. Childhood sporadic pheochromocytoma: Clinical profile and outcome in 19 patients.

Otsuka F, Ogura T, Nakagawa M, Hayakawa N, Kataoka H, Oishi T, Makino H. Normotensive bilateral pheochromocytoma with Lindau disease: case report. Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH, Naruse M, Pacak K, Young WF. Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline.

Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM, Edwards H. Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J.

Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology 1. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C.

Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.

Lancet London, England. Surendran P, Drenos F, Young R, Warren H, Cook JP, Manning AK, Grarup N, Sim X, Barnes DR, Witkowska K, Staley JR, Tragante V, Tukiainen T, Yaghootkar H, Masca N, Freitag DF, Ferreira T, Giannakopoulou O, Tinker A, Harakalova M, Mihailov E, Liu C, Kraja AT, Fallgaard Nielsen S, Rasheed A, Samuel M, Zhao W, Bonnycastle LL, Jackson AU, Narisu N, Swift AJ, Southam L, Marten J, Huyghe JR, Stančáková A, Fava C, Ohlsson T, Matchan A, Stirrups KE, Bork-Jensen J, Gjesing AP, Kontto J, Perola M, Shaw-Hawkins S, Havulinna AS, Zhang H, Donnelly LA, Groves CJ, Rayner NW, Neville MJ, Robertson NR, Yiorkas AM, Herzig K-H, Kajantie E, Zhang W, Willems SM, Lannfelt L, Malerba G, Soranzo N, Trabetti E, Verweij N, Evangelou E, Moayyeri A, Vergnaud A-C, Nelson CP, Poveda A, Varga T V, Caslake M, de Craen AJ, Trompet S, Luan J, Scott RA, Harris SE, Liewald DC, Marioni R, Menni C, Farmaki A-E, Hallmans G, Renström F, Huffman JE, Hassinen M, Burgess S, Vasan RS, Felix JF.

Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Liu C, Kraja AT, Smith JA, Brody JA, Franceschini N, Bis JC, Rice K, Morrison AC, Lu Y, Weiss S, Guo X, Palmas W, Martin LW, Chen YDI, Surendran P, Drenos F, Cook JP, Auer PL, Chu AY, Giri A, Zhao W, Jakobsdottir J, Lin LA, Stafford JM, Amin N, Mei H, Yao J, Voorman A, Larson MG, Grove ML, Smith A V.

Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci. Melcescu E, Koch CA. Endocrine Hypertension. Accessed December 21, Vasan RS, Evans JC, Larson MG, Wilson PWF, Meigs JB, Rifai N, Benjamin EJ, Levy D.

Serum aldosterone and the incidence of hypertension in nonhypertensive persons. Seiler L, Rump LC, Schulte-Mönting J, Slawik M, Borm K, Pavenstädt H, Beuschlein F, Reincke M. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.

Streeten DHP, Tomycz N, Anderson GH. Reliability of screening methods for the diagnosis of primary aldosteronism. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M.

Ulick S, Blumenfeld JD, Atlas SA, Wang JZ, Vaughan ED. The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism.

Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, Van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Asbach E, Williams TA, Reincke M. Recent Developments in Primary Aldosteronism. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF.

The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline.

Toniato A, Bernante P, Rossi GP, Pelizzo MR. The role of adrenal venous sampling in the surgical management of primary aldosteronism. Gordon RD, Stowasser M.

Familial forms broaden the horizons for primary aldosteronism. Trends Endocrinol. Stowasser M, Gordon RD. Primary aldosteronism: From genesis to genetics. Melcescu E, Phillips J, Moll G, Subauste JS, Koch CA.

Grim CE, Weinberger MH. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism. Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P, Gordon RD, Stratakis CA. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 7p Charmandari E, Sertedaki A, Kino T, Merakou C, Hoffman DA, Hatch MM, Hurt DE, Lin L, Xekouki P, Stratakis CA, Chrousos GP.

A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. Weinberger MH, Fineberg NS. The diagnosis of primary aldosteronism and separation of two major subtypes.

Wulczyn K, Perez-Reyes E, Nussbaum RL, Park M. Primary aldosteronism associated with a germline variant in CACNA1H.

BMJ Case Rep. Seidel E, Schewe J, Scholl UI. Genetic causes of primary aldosteronism. Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M, Bidlingmaier M.

Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Aldosterone assays: an urgent need for improvement. Palermo M, Quinkler M, Stewart PM. Apparent mineralocorticoid excess syndrome: an overview.

Vaidya A, Dluhy R. com, Inc; Tsiavos V, Markou A, Papanastasiou L, Kounadi T, Androulakis II, Voulgaris N, Zachaki A, Kassi E, Kaltsas G, Chrousos GP, Piaditis GP. A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism.

Primary aldosteronism - Careful investigation is essential and rewarding. Molecular and Cellular Endocrinology. Fourkiotis V, Vonend O, Diederich S, Fischer E, Lang K, Endres S, Beuschlein F, Willenberg HS, Rump LC, Allolio B, Reincke M, Quinkler M.

Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism. Jansen PM, van den Meiracker AH, Jan Danser AH. Aldosterone synthase inhibitors: pharmacological and clinical aspects.

Primary aldosteronism: Learning from the study of familial varieties. Sukor N, Gordon RD, Yee KK, Jones M, Stowasser M. Role of unilateral adrenalectomy in bilateral primary aldosteronism: A year single center experience. Letavernier E, Peyrard S, Amar L, Zinzindohoué F, Fiquet B, Plouin P-F.

Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. Meyer A, Brabant G, Behrend M.

Long-term follow-up after adrenalectomy for primary aldosteronism. Rossi GP. Surgically correctable hypertension caused by primary aldosteronism. Best Pract. Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Novello M, Favret G, Melis A, Cavarape A, Sechi LA.

Insulin sensitivity in patients with primary aldosteronism: A follow-up study. Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF.

Fasting plasma glucose and serum lipids in patients with primary aldosteronism a controlled cross-sectional study. Kempers MJE, Lenders JWM, Van Outheusden L, Van Der Wilt GJ, Kool LJS, Hermus ARMM, Deinum J.

Systematic review: Diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism.

Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT. Occurrence of pheochromocytoma in Rochester, Minnesota, through Mayo Clin. Guerrero MA, Schreinemakers JMJ, Vriens MR, Suh I, Hwang J, Shen WT, Gosnell J, Clark OH, Duh Q-Y.

Clinical spectrum of pheochromocytoma. Erlic Z, Rybicki L, Peczkowska M, Golcher H, Kann PH, Brauckhoff M, Müssig K, Muresan M, Schäffler A, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plöckinger U, Petersenn S, Zabolotny D, Kollukch O, Yaremchuk S, Januszewicz A, Walz MK, Eng C, Neumann HPH.

Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Cancer Res. Jiménez C, Cote G, Arnold A, Gagel RF.

Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? Eisenhofer G, Lenders JWM, Goldstein DS, Mannelli M, Csako G, Walther MM, Brouwers FM, Pacak K.

Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein SR, Vortmeyer A, Mannelli M, Goldstein DS, Linehan WM, Lenders JWM, Pacak K.

Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. Neumann HPH, Vortmeyer A, Schmidt D, Werner M, Erlic Z, Cascon A, Bausch B, Januszewicz A, Eng C.

Evidence of MEN-2 in the original description of classic pheochromocytoma. Bravo EL, Tagle R. Pheochromocytoma: State-of-the-art and future prospects. Lu Y, Li P, Gan W, Zhao X, Shen S, Feng W, Xu Q, Bi Y, Guo H, Zhu D.

Clinical and Pathological Characteristics of Hypertensive and Normotensive Adrenal Pheochromocytomas. Prejbisz A, Lenders JWM, Eisenhofer G, Januszewicz A. Cardiovascular manifestations of phaeochromocytoma. Giavarini A, Chedid A, Bobrie G, Plouin PF, Hagège A, Amar L.

Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Y-Hassan S.

Clinical Features and Outcome of Pheochromocytoma-Induced Takotsubo Syndrome. Analysis of 80 Published Cases. Gagnon N, Mansour S, Bitton Y, Bourdeau I. Miehle K, Kratzsch J, Lenders JWM, Kluge R, Paschke R, Koch CA.

Adrenal incidentaloma diagnosed as pheochromocytoma by plasma chromogranin A and plasma metanephrines. Bausch B, Tischler AS, Schmid KW, Leijon H, Eng C, Neumann HPH.

Max Schottelius: Pioneer in Pheochromocytoma. Eisenhofer G, Lenders JWM, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ, Pacak K.

Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Niculescu DA, Ismail G, Poiana C. Plasma free metanephrine and normetanephrine levels are increased in patients with chronic kidney disease.

Eisenhofer G, Lattke P, Herberg M, Siegert G, Qin N, Därr R, Hoyer J, Villringer A, Prejbisz A, Januszewicz A, Remaley A, Martucci V, Pacak K, Ross HA, Sweep FCGJ, Lenders JWM.

Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma. De Jong WHA, Eisenhofer G, Post WJ, Muskiet FAJ, De Vries EGE, Kema IP. Dietary influences on plasma and urinary metanephrines: Implications for diagnosis of catecholamine-producing tumors.

Neumann HPH, Young WF, Eng C. Pheochromocytoma and Paraganglioma. Majumdar S, Friedrich CA, Koch CA, Megason GC, Fratkin JD, Moll GW. Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma. Blood Cancer.

Timmers HJLM, Gimenez-Roqueplo A-P, Mannelli M, Pacak K. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Bhatia KSS, Ismail MM, Sahdev A, Rockall AG, Hogarth K, Canizales A, Avril N, Monson JP, Grossman AB, Reznek RH.

Lenders JWM, Pacak K, Walther MM, Marston Linehan W, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G.

Biochemical diagnosis of pheochromocytoma: Which test is best? Koch CA. Should I-MIBG scintigraphy be part of the workup for pheochromocytomas? Koopmans KP, Jager PL, Kema IP, Kerstens MN, Albers F, Dullaart RPF. Mazza A, Beltramello G, Armigliato M, Montemurro D, Zorzan S, Zuin M, Rampin L, Marzola MC, Grassetto G, Al-Nahhas A, Rubello D.

Arterial hypertension and thyroid disorders: What is important to know in clinical practice? Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG.

Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.

Neumann HPH, Tsoy U, Bancos I, Amodru V, Walz MK, Tirosh A, Kaur RJ, McKenzie T, Qi X, Bandgar T, Petrov R, Yukina MY, Roslyakova A, Van Der Horst-Schrivers ANA, Berends AMA, Hoff AO, Castroneves LA, Ferrara AM, Rizzati S, Mian C, Dvorakova S, Hasse-Lazar K, Kvachenyuk A, Peczkowska M, Loli P, Erenler F, Krauss T, Almeida MQ, Liu L, Zhu F, Recasens M, Wohllk N, Corssmit EPM, Shafigullina Z, Calissendorff J, Grozinsky-Glasberg S, Kunavisarut T, Schalin-Jäntti C, Castinetti F, Vlček P, Beltsevich D, Egorov VI, Schiavi F, Links TP, Lechan RM, Bausch B, Young WF, Eng C.

Comparison of Pheochromocytoma-Specific Morbidity and Mortality among Adults with Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy. JAMA Netw. Castinetti F, Waguespack SG, Machens A, Uchino S, Hasse-Lazar K, Sanso G, Else T, Dvorakova S, Qi XP, Elisei R, Maia AL, Glod J, Lourenço DM, Valdes N, Mathiesen J, Wohllk N, Bandgar TR, Drui D, Korbonits M, Druce MR, Brain C, Kurzawinski T, Patocs A, Bugalho MJ, Lacroix A, Caron P, Fainstein-Day P, Borson Chazot F, Klein M, Links TP, Letizia C, Fugazzola L, Chabre O, Canu L, Cohen R, Tabarin A, Spehar Uroic A, Maiter D, Laboureau S, Mian C, Peczkowska M, Sebag F, Brue T, Mirebeau-Prunier D, Leclerc L, Bausch B, Berdelou A, Sukurai A, Vlcek P, Krajewska J, Barontini M, Vaz Ferreira Vargas C, Valerio L, Ceolin L, Akshintala S, Hoff A, Godballe C, Jarzab B, Jimenez C, Eng C, Imai T, Schlumberger M, Grubbs E, Dralle H, Neumann HP, Baudin E.

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Diabetes Endocrinol. Brauckhoff M, Gimm O, Thanh PN, Bär A, Ukkat J, Brauckhoff K, Bönsch T, Dralle H, McHenry CR, Thompson GB, Duh QY.

Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy. In: Surgery. Mosby Inc. Lodish MB, Sinaii N, Patronas N, Batista DL, Keil M, Samuel J, Moran J, Verma S, Popovic J, Stratakis CA.

Blood pressure in pediatric patients with Cushing syndrome. Isidori AM, Graziadio C, Paragliola RM, Cozzolino A, Ambrogio AG, Colao A, Corsello SM, Pivonello R. Zacharieva S, Orbetzova M, Stoynev A, Shigarminova R, Yaneva M, Kalinov K, Nachev E, Elenkova A. Baid S, Nieman LK.

Glucocorticoid excess and hypertension. Juszczak A, Sulentic P, Grossman A. Accessed January 16, Torpy DJ, Mullen N, Ilias I, Nieman LK. Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM.

Nieman LK, Biller BMK, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A. Endocrine Society. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM.

ESEC Guideline incidentaloma adrenal. Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A. Chatzellis E, Kaltsas G. Adrenal Incidentalomas. Zeiger MA, Thompson GB, Duh Q-Y, Hamrahian AH, Angelos P, Elaraj D, Fishman E, Kharlip J. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations.

Hannah-Shmouni F, Melcescu E, Koch CA. Testing for Endocrine Hypertension. Gläsker S, Neumann HPH, Koch CA, Vortmeyer A. Von Hippel-Lindau Disease. Kino T, Vottero A, Charmandari E, Chrousos GP.

Chrousos GP, Vingerhoeds A, Brandon D, Eil C, Pugeat M, DeVroede M, Loriaux DL, Lipsett MB. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. Charmandari E, Kino T, Ichijo T, Chrousos GP.

Generalized glucocorticoid resistance: Clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. Nebesio TD, Eugster EA. Observation of hypertension in children with hydroxylase deficiency: a preliminary report.

Finkielstain GP, Kim MS, Sinaii N, Nishitani M, Van Ryzin C, Hill SC, Reynolds JC, Hanna RM, Merke DP. Clinical characteristics of a cohort of patients with congenital adrenal hyperplasia.

Kim MS, Merke DP. Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to hydroxylase deficiency. Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.

A study of 25 patients. New MI, Geller DS, Fallo F, Wilson RC. Monogenic low renin hypertension. Mimouni M, Kaufman H, Roitman A, Morag C, Sadan N.

Hypertension in a neonate with 11 β-hydroxylase deficiency. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HFL, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC.

Congenital adrenal hyperplasia due to steroid hydroxylase deficiency: An Endocrine Society clinical practice guideline. Speiser PW, White PC.

Congenital adrenal hyperplasia. Melcescu E, Griswold M, Xiang L, Belk S, Montgomery D, Bray M, Del Ben KS, Uwaifo GI, Marshall GD, Koch CA. Prevalence and cardiometabolic associations of the glucocorticoid receptor gene polymorphisms NS and BclI in obese and non-obese black and white Mississippians.

Hormones Athens. Hochberg Z, Even L, Zadik Z. Mineralocorticoids in the mechanism of gynecomastia in adrenal hyperplasia caused by 11β-hydroxylase deficiency. Kacem M, Moussa A, Khochtali I, Nabouli R, Morel Y, Zakhama A.

Bilateral adrenalectomy for severe hypertension in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency: Long term follow-up. New MI. Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. Wong S-L, Shu S-G, Tsai C-R. Seventeen alpha-hydroxylase deficiency. Costa-Santos M, Kater CE, Auchus RJ.

Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with hydroxylase deficiency. Müssig K, Wehrmann M, Horger M, Maser-Gluth C, Häring HU, Overkamp D. Adrenocortical carcinoma producing deoxycorticosterone: A rare cause of mineralocorticoid hypertension.

Carvajal CA, Gonzalez AA, Romero DG, González A, Mosso LM, Lagos ET, Hevia M del P, Rosati MP, Perez-Acle TO, Gomez-Sanchez CE, Montero JA, Fardella CE. Two homozygous mutations in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess.

Lin-Su K, Zhou P, Arora N, Betensky BP, New MI, Wilson RC. In vitro expression studies of a novel mutation delta in a patient affected with apparent mineralocorticoid excess. New MI, Levine LS, Biglieri EG, Pareira J, Ulick S.

Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei JQ, Shackleton CH, Funder JW, New MI. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess.

Stewart PM, Krozowski ZS, Gupta A, Milford D V. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene. Stewart PM, Corrie JE, Shackleton CH, Edwards CR. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.

Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science Funder JW, Pearce PT, Smith R, Smith AI.

Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Heilmann P, Buchheim E, Wacker J, Ziegler R. Alteration of the activity of the 11beta-hydroxysteroid dehydrogenase in pregnancy: relevance for the development of pregnancy-induced hypertension?

Quinkler M, Oelkers W, Diederich S. In Vivo Measurement of Renal 11β-Hydroxysteroid Dehydrogenase Type 2 Activity. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FTF, Sigler PB, Lifton RP.

Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Liddle GW, Bledsoe T, Coppage WS. Hypertension reviews. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction.

Geller DS. Mineralocorticoid resistance. Klemm SA, Gordon RD, Tunny TJ, Thompson RE. Wilson FH, Disse-Nicodème S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford D V, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP.

Human hypertension caused by mutations in WNK kinases. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: Update in diagnosis and management. Sakoh T, Sekine A, Mori T, Mizuno H, Kawada M, Hiramatsu R, Hasegawa E, Hayami N, Yamanouchi M, Suwabe T, Sawa N, Ubara Y, Fujimaru T, Sohara E, Shinichi U, Hoshino J, Takaichi K.

A familial case of pseudohypoaldosteronism type II PHA2 with a novel mutation DN in the acidic motif in WNK4. genomic Med. Xie J, Craig L, Cobb MH, Huang C-L. Tobin MD, Raleigh SM, Newhouse S, Braund P, Bodycote C, Ogleby J, Cross D, Gracey J, Hayes S, Smith T, Ridge C, Caulfield M, Sheehan NA, Munroe PB, Burton PR, Samani NJ.

Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Koch CA, Bornstein SR, Birkenfeld AL.

Haffner SM, Ruilope L, Dahlöf B, Abadie E, Kupfer S, Zannad F. Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials.

Saad MF, Rewers M, Selby J, Howard G, Jinagouda S, Fahmi S, Zaccaro D, Bergman RN, Savage PJ, Haffner SM. Insulin resistance and hypertension: The insulin resistance atherosclerosis study. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S.

Insulin resistance in essential hypertension. Levy J, Gavin JR, Hammerman MR, Avioli L V. Bogaert YE, Linas S. The role of obesity in the pathogenesis of hypertension. Graessler J, Schwudke D, Schwarz PEH, Herzog R, Shevchenko A, Bornstein SR.

Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One. McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitch M, Krutzik S.

Enhanced parathyroid function in essential hypertension: A homeostatic response to a urinary calcium leak. Bukoski RD, Ishibashi K, Bian K. Vascular actions of the calcium-regulating hormones.

Hulter HN, Melby JC, Peterson JC, Cooke CR. Chronic continuous PTH infusion results in hypertension in normal subjects. Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R, Hunt DL. Effects of dietary calcium supplementation on blood pressure.

A meta-analysis of randomized controlled trials. Allender PS, Cutler JA, Follmann D, Cappuccio FP, Pryer J, Elliott P. Dietary calcium and blood pressure: A meta-analysis of randomized clinical trials. Bollerslev J, Rosen T, Mollerup CL, Nordenström J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T, Jansson S.

Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. Bollerslev J, Jansson S, Mollerup CL, Nordenström J, Lundgren E, Tørring O, Varhaug J-E, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Rubin MR, Maurer MS, McMahon DJ, Bilezikian JP, Silverberg SJ. Arterial stiffness in mild primary hyperparathyroidism.

Walker MD, Fleischer J, Rundek T, McMahon DJ, Homma S, Sacco R, Silverberg SJ. Carotid vascular abnormalities in primary hyperparathyroidism. Concistrè A, Grillo A, La Torre G, Carretta R, Fabris B, Petramala L, Marinelli C, Rebellato A, Fallo F, Letizia C.

Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism. Storvall S, Ryhänen EM, Heiskanen I, Sintonen H, Roine RP, Schalin-Jäntti C. Surgery Significantly Improves Neurocognition, Sleep, and Blood Pressure in Primary Hyperparathyroidism: A 3-Year Prospective Follow-Up Study.

Ejlsmark-Svensson H, Rolighed L, Rejnmark L. Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial. Ekmekci A, Abaci N, Colak Ozbey N, Agayev A, Aksakal N, Oflaz H, Erginel-Unaltuna N, Erbil Y. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT.

Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the fourth international workshop. In: Journal of Clinical Endocrinology and Metabolism. Endocrine Society; — Danzi S, Klein I. Thyroid hormone and blood pressure regulation.

Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension.

Kempf T, Wollert KC. Risk stratification in critically ill patients: GDF scores in adult respiratory distress syndrome. Berta E, Lengyel I, Halmi S, Zrínyi M, Erdei A, Harangi M, Páll D, Nagy E V, Bodor M.

Hypertension in Thyroid Disorders. Fountoulakis S, Tsatsoulis A. Molecular genetic aspects and pathophysiology of endocrine hypertension. Iglesias P, Acosta M, Sánchez R, Fernández-Reyes MJ, Mon C, Díez JJ. Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function.

Völzke H, Alte D, Dörr M, Wallaschofski H, John U, Felix SB, Rettig R. The association between subclinical hyperthyroidism and blood pressure in a population-based study. Biondi B, Cooper DS.

The clinical significance of subclinical thyroid dysfunction. Streeten DHP, Anderson GH, Howland T, Chiang R, Smulyan H. Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Iqbal A, Schirmer H, Lunde P, Figenschau Y, Rasmussen K, Jorde R.

Thyroid stimulating hormone and left ventricular function. Stabouli S, Papakatsika S, Kotsis V. Hypothyroidism and hypertension. Expert Rev. Ittermann T, Thamm M, Wallaschofski H, Rettig R, Völzke H. Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents.

Cai Y, Ren Y, Shi J. Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management.

Rizzoni D, Porteri E, Giustina A, De Ciuceis C, Sleiman I, Boari GEM, Castellano M, Muiesan ML, Bonadonna S, Burattin A, Cerudelli B, Agabiti-Rosei E. Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Dallas, Tex. Lombardi G, Galdiero M, Auriemma RS, Pivonello R, Colao A.

Acromegaly and the cardiovascular system. Colao A, Terzolo M, Bondanelli M, Galderisi M, Vitale G, Reimondo G, Ambrosio MR, Pivonello R, Lombardi G, Angeli A.

degli Uberti EC. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in hypertensive acromegalic patients on hypertensive treatment.

Bielohuby M, Roemmler J, Manolopoulou J, Johnsen I, Sawitzky M, Schopohl J, Reincke M, Wolf E, Hoeflich A, Bidlingmaier M. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.

Sardella C, Urbani C, Lombardi M, Nuzzo A, Manetti L, Lupi I, Rossi G, Del Sarto S, Scattina I, Di Bello V, Martino E, Bogazzi F. The beneficial effect of acromegaly control on blood pressure values in normotensive patients. González B, Vargas G, de Los Monteros ALE, Mendoza V, Mercado M.

Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly. Ullah MI, Uwaifo GI, Nicholas WC, Koch CA. Does vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms.

Kazi M, Geraci SA, Koch CA. Considerations for the diagnosis and treatment of testosterone deficiency in elderly men. Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M.

The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Sattler FR, Castaneda-Sceppa C, Binder EF, Schroeder ET, Wang Y, Bhasin S, Kawakubo M, Stewart Y, Yarasheski KE, Ulloor J, Colletti P, Roubenoff R, Azen SP. Testosterone and growth hormone improve body composition and muscle performance in older men.

Widdowson WM, Gibney J. The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis. Mekala KC, Tritos NA. Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis. Zhang J, Ge R, Matte-Martone C, Goodwin J, Shlomchik WD, Mamula MJ, Kooshkabadi A, Hardy MP, Geller D.

Characterization of a novel gain of function glucocorticoid receptor knock-in mouse. Michailidou Z, Carter RN, Marshall E, Sutherland HG, Brownstein DG, Owen E, Cockett K, Kelly V, Ramage L, Al-Dujaili EAS, Ross M, Maraki I, Newton K, Holmes MC, Seckl JR, Morton NM, Kenyon CJ, Chapman KE.

Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet.

FASEB J. Copyright © , MDText. Bookshelf ID: NBK PMID: PubReader Print View Cite this Page Koch C, Papadopoulou-Marketou N, Chrousos GP. Overview of Endocrine Hypertension. In: Feingold KR, Anawalt B, Blackman MR, et al.

In this Page. Links to www. View this chapter in Endotext. Related information. PMC PubMed Central citations. Similar articles in PubMed.

Review Testing for Endocrine Hypertension. Review 11Beta-hydroxylase deficiency and other syndromes of mineralocorticoid excess as a rare cause of endocrine hypertension.

Horm Metab Res. Epub Aug Review Adrenal Disorders in the Tropics. Mukhopadhyay P, Pandit K, Ghosh S. Review Endocrine Changes in Obesity. Ylli D, Sidhu S, Parikh T, Burman KD. Review Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome. Nicolaides NC, Kino T, Chrousos G, Charmandari E.

Recent Activity. Clear Turn Off Turn On. Overview of Endocrine Hypertension - Endotext. Follow NCBI. Twitter Facebook LinkedIn GitHub NCBI Insights Blog. Connect with NLM Twitter Facebook Youtube. NLM NIH HHS USA. Adrenal-dependent causes. Renal causes 2. Pheochromocytoma and sympathetic paraganglioma.

Polycystic kidney disease. Primary aldosteronism. Chronic kidney disease. Urinary tract obstruction. Renin-producing tumor. Liddle syndrome. Renovascular causes. Beta blockers: How do they affect exercise?

Birth control pill FAQ Blood glucose meters Blood glucose monitors Blood pressure: Can it be higher in one arm? Blood pressure chart Blood pressure cuff: Does size matter?

Blood pressure: Does it have a daily pattern? Blood pressure: Is it affected by cold weather? Blood pressure medication: Still necessary if I lose weight? Blood pressure medications: Can they raise my triglycerides? Blood pressure readings: Why higher at home?

Blood pressure test Blood pressure tip: Get more potassium Blood sugar levels can fluctuate for many reasons Blood sugar testing: Why, when and how Bone and joint problems associated with diabetes How kidneys work Bump on the head: When is it a serious head injury?

Caffeine and hypertension Calcium channel blockers Calcium supplements: Do they interfere with blood pressure drugs? Can whole-grain foods lower blood pressure? Central-acting agents Choosing blood pressure medicines Chronic daily headaches Chronic kidney disease Chronic kidney disease: Is a clinical trial right for me?

Coarctation of the aorta COVID Who's at higher risk of serious symptoms? Cushing syndrome DASH diet DASH diet: Recommended servings Sample DASH menus Diabetes Diabetes and depression: Coping with the two conditions Diabetes and exercise: When to monitor your blood sugar Diabetes and heat 10 ways to avoid diabetes complications Diabetes diet: Should I avoid sweet fruits?

Diabetes diet: Create your healthy-eating plan Diabetes foods: Can I substitute honey for sugar? Diabetes and liver Diabetes management: How lifestyle, daily routine affect blood sugar Diabetes symptoms Diabetes treatment: Can cinnamon lower blood sugar? Using insulin Diuretics Diuretics: A cause of low potassium?

Diuretics: Cause of gout? Dizziness Do infrared saunas have any health benefits? Drug addiction substance use disorder Eating right for chronic kidney disease High blood pressure and exercise Fibromuscular dysplasia Free blood pressure machines: Are they accurate?

Home blood pressure monitoring Glomerulonephritis Glycemic index: A helpful tool for diabetes? Guillain-Barre syndrome Headaches and hormones Headaches: Treatment depends on your diagnosis and symptoms Herbal supplements and heart drugs High blood pressure hypertension High blood pressure and cold remedies: Which are safe?

High blood pressure and sex High blood pressure dangers How does IgA nephropathy Berger's disease cause kidney damage? How opioid use disorder occurs How to tell if a loved one is abusing opioids What is hypertension? A Mayo Clinic expert explains. Hypertension FAQs Hypertensive crisis: What are the symptoms?

Hypothermia I have IgA nephrology. Will I need a kidney transplant? IgA nephropathy Berger disease Insulin and weight gain Intracranial hematoma Isolated systolic hypertension: A health concern?

What is kidney disease? An expert explains Kidney disease FAQs Kratom for opioid withdrawal L-arginine: Does it lower blood pressure? Late-night eating: OK if you have diabetes? Lead poisoning Living with IgA nephropathy Berger's disease and C3G Low-phosphorus diet: Helpful for kidney disease?

Medications and supplements that can raise your blood pressure Molar pregnancy MRI: Is gadolinium safe for people with kidney problems? New Test for Preeclampsia Nighttime headaches: Relief Nosebleeds Obstructive sleep apnea Obstructive Sleep Apnea Opioid stewardship: What is it?

Pain Management Pheochromocytoma Picnic Problems: High Sodium Pituitary tumors Polycystic kidney disease Polypill: Does it treat heart disease? Porphyria Postpartum preeclampsia Preeclampsia Prescription drug abuse Primary aldosteronism Pulse pressure: An indicator of heart health?

Mayo Clinic Minute: Rattlesnakes, scorpions and other desert dangers Reactive hypoglycemia: What can I do? Renal diet for vegetarians Resperate: Can it help reduce blood pressure?

Scorpion sting Secondary hypertension Serotonin syndrome Sleep deprivation: A cause of high blood pressure? Sleep tips Snoring Sodium Spider bites Stress and high blood pressure Symptom Checker Takayasu's arteritis Tapering off opioids: When and how Tetanus Tetanus shots: Is it risky to receive 'extra' boosters?

The dawn phenomenon: What can you do? Understanding complement 3 glomerulopathy C3G Understanding IgA nephropathy Berger's disease Vasodilators Vegetarian diet: Can it help me control my diabetes? Vesicoureteral reflux Video: Heart and circulatory system How to measure blood pressure using a manual monitor How to measure blood pressure using an automatic monitor Obstructive sleep apnea: What happens?

What is blood pressure? Can a lack of vitamin D cause high blood pressure? What are opioids and why are they dangerous? White coat hypertension Wrist blood pressure monitors: Are they accurate? Effectively managing chronic kidney disease Show more related content. Mayo Clinic Press Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.

Mayo Clinic on Incontinence - Mayo Clinic Press Mayo Clinic on Incontinence The Essential Diabetes Book - Mayo Clinic Press The Essential Diabetes Book Mayo Clinic on Hearing and Balance - Mayo Clinic Press Mayo Clinic on Hearing and Balance FREE Mayo Clinic Diet Assessment - Mayo Clinic Press FREE Mayo Clinic Diet Assessment Mayo Clinic Health Letter - FREE book - Mayo Clinic Press Mayo Clinic Health Letter - FREE book.

FAQ Home Menopause and high blood pressure Whats the connection. Show the heart some love! Give Today. Help us advance cardiovascular medicine. Find a doctor. Explore careers. Sign up for free e-newsletters. About Mayo Clinic. About this Site. Contact Us. Health Information Policy.

Media Requests. News Network. Price Transparency.

Endocrine hormlnal refers to high blood pressure hypertension caused Hypertensiob the abnormal Hyypertension of hormones. Imbalancfs most common form of Hypertensjon hypertension is Hypertension and hormonal imbalances Artichoke-centric Mediterranean cuisine PAalso known as Conn syndrome. Hypertnsion primary aldosteronism, the adrenal glands, Hypertension and hormonal imbalances sit on top of each kidney, produce too much aldosterone a hormone that retains salt in the body. This can lead to excess salt and fluid retention and increased blood pressure. It also increases the risk of heart arrhythmia, heart attack and stroke more than ordinary forms of hypertension. Primary aldosteronism affects five to 10 per cent of those with hypertension but often goes undiagnosed. Caused by a hormone imbalance, primary aldosteronism is often undiagnosed or given incorrect treatment. New research shows imbalnces risk Mental acuity preservation Hypertension and hormonal imbalances from prostate Hypertension and hormonal imbalances. Discrimination at work is linked imbalxnces high blood pressure. Hoemonal fingers and imbalwnces Poor circulation or Raynaud's phenomenon? High blood pressure — which has no symptoms or warning signs — can harm your blood vessels, heart, brain, eyes, and kidneys. A combination of unhealthy habits, such as smoking, a poor diet, and lack of exercise, can contribute to a rise in blood pressure.